| Dr Sandeep K Reddy, MD | |
|
2040 E Mariposa Ave, El Segundo, CA 90245 | |
| (213) 266-5600 | |
| (213) 477-2344 |
| Full Name | Dr Sandeep K Reddy |
|---|---|
| Gender | Male |
| Speciality | Specialist |
| Location | 2040 E Mariposa Ave, El Segundo, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275601775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A65510 (California) | Secondary |
| 174400000X | Specialist | A65510 (California) | Primary |
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
Fujitsu Laboratories Ltd. announced the development of a technology that accelerates database analyses of the correlations between genomic variations and environmental information, such as disease and lifestyle habits. This technology speeds up the process by a factor of roughly 400 compared to existing methods.
Researchers at the Johns Hopkins Bloomberg School of Public Health have found evidence of a novel pathway for potential human exposure to antibiotic-resistant bacteria from intensively raised poultry-driving behind the trucks transporting broiler chickens from farm to slaughterhouse.
While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment.
A new study provides valuable insight into a previously undescribed mechanism that regulates a prominent cancer-associated protein.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
› Verified 3 days ago
| Entity Name | Immuno-oncology Clinic Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215463799 PECOS PAC ID: 0244509057 Enrollment ID: O20170711002269 |
News Archive
Fujitsu Laboratories Ltd. announced the development of a technology that accelerates database analyses of the correlations between genomic variations and environmental information, such as disease and lifestyle habits. This technology speeds up the process by a factor of roughly 400 compared to existing methods.
Researchers at the Johns Hopkins Bloomberg School of Public Health have found evidence of a novel pathway for potential human exposure to antibiotic-resistant bacteria from intensively raised poultry-driving behind the trucks transporting broiler chickens from farm to slaughterhouse.
While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment.
A new study provides valuable insight into a previously undescribed mechanism that regulates a prominent cancer-associated protein.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sandeep K Reddy, MD 2040 E Mariposa Ave, El Segundo, CA 90245-5027 Ph: (213) 266-5600 | Dr Sandeep K Reddy, MD 2040 E Mariposa Ave, El Segundo, CA 90245 Ph: (213) 266-5600 |
News Archive
Fujitsu Laboratories Ltd. announced the development of a technology that accelerates database analyses of the correlations between genomic variations and environmental information, such as disease and lifestyle habits. This technology speeds up the process by a factor of roughly 400 compared to existing methods.
Researchers at the Johns Hopkins Bloomberg School of Public Health have found evidence of a novel pathway for potential human exposure to antibiotic-resistant bacteria from intensively raised poultry-driving behind the trucks transporting broiler chickens from farm to slaughterhouse.
While the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment.
A new study provides valuable insight into a previously undescribed mechanism that regulates a prominent cancer-associated protein.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
› Verified 3 days ago